Evidence map›Paper›PMID 38305633›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

IL-15 Complex-Induced IL-10 Enhances Plasmodium-specific CD4+ T Follicular Helper Differentiation and Antibody Production.

Morgan Bravo, Thamotharampillai Dileepan, Molly Dolan, Jacob Hildebrand, Jordan Wolford, Isabelle D Hanson, Sara E Hamilton, Anne E Frosch, Kristina S Burrack

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Morgan BravoHennepin Healthcare Research Institute, Minneapolis, MN.ORCID 0000-0003-3821-5931
Thamotharampillai DileepanCenter for Immunology, University of Minnesota, Minneapolis, MN.ORCID 0000-0002-2810-6996
Molly DolanHennepin Healthcare Research Institute, Minneapolis, MN.ORCID 0009-0007-0206-3274
Jacob HildebrandCenter for Immunology, University of Minnesota, Minneapolis, MN.
Jordan WolfordHennepin Healthcare Research Institute, Minneapolis, MN.ORCID 0009-0000-1408-2623
Isabelle D HansonHennepin Healthcare Research Institute, Minneapolis, MN.
Sara E HamiltonCenter for Immunology, University of Minnesota, Minneapolis, MN.ORCID 0000-0002-3768-7622
Anne E FroschHennepin Healthcare Research Institute, Minneapolis, MN.
Kristina S BurrackHennepin Healthcare Research Institute, Minneapolis, MN.ORCID 0000-0002-6931-226X
Hennepin Healthcare Research Institute · USUniversity of Minnesota Medical Center · USUniversity of Minnesota · US

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
IMMUNOLOGY TRAINING PROGRAMT32AI007313 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Carla Rothlin · 1989 to 2026
$5.7M
Regulation of the Immune Response to Plasmodium by IL-10 Producing Natural Killer CellsR01AI143828 · NIAID · UNIVERSITY OF MINNESOTA · PI HAMILTON HART, SARA ELIZABETH · 2019 to 2023
$2.3M
Memory T follicular helper cell kinetics and localization during recall immune responses to tetanus vaccinationK08AI141761 · NIAID · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI FROSCH, ANNE ELIZABETH PARKER · 2019 to 2023
$984k
Enhancing T and B cell responses to Plasmodium infection and vaccination via IL-15R01AI185750 · NIAID · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI BURRACK, KRISTINA STOERMER · 2024 to 2024
$607k
Investigating IL-10-producing suppressive NK cellsK22AI143969 · NIAID · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI BURRACK, KRISTINA STOERMER · 2020 to 2021
$342k
NCATS NIH HHS UL1 TR000114NIAID NIH HHS K08 AI141761NIAID NIH HHS K22 AI143969NIAID NIH HHS R01 AI143828NIAID NIH HHS R01 AI185750NIAID NIH HHS T32 AI007313
6 · The paper itself

Abstract

Malaria, which results from infection with Plasmodium parasites, remains a major public health problem. Although humans do not develop long-lived, sterilizing immunity, protection against symptomatic disease develops after repeated exposure to Plasmodium parasites and correlates with the acquisition of humoral immunity. Despite the established role Abs play in protection from malaria disease, dysregulated inflammation is thought to contribute to the suboptimal immune response to Plasmodium infection. Plasmodium berghei ANKA (PbA) infection results in a fatal severe malaria disease in mice. We previously demonstrated that treatment of mice with IL-15 complex (IL-15C; IL-15 bound to an IL-15Rα-Fc fusion protein) induces IL-10 expression in NK cells, which protects mice from PbA-induced death. Using a novel MHC class II tetramer to identify PbA-specific CD4+ T cells, in this study we demonstrate that IL-15C treatment enhances T follicular helper (Tfh) differentiation and modulates cytokine production by CD4+ T cells. Moreover, genetic deletion of NK cell-derived IL-10 or IL-10R expression on T cells prevents IL-15C-induced Tfh differentiation. Additionally, IL-15C treatment results in increased anti-PbA IgG Ab levels and improves survival following reinfection. Overall, these data demonstrate that IL-15C treatment, via its induction of IL-10 from NK cells, modulates the dysregulated inflammation during Plasmodium infection to promote Tfh differentiation and Ab generation, correlating with improved survival from reinfection. These findings will facilitate improved control of malaria infection and protection from disease by informing therapeutic strategies and vaccine design.

Indexed as

MalariaPlasmodiumAnimalsAntibody FormationCD4-Positive T-LymphocytesHumansInflammationInterleukin-10Interleukin-15MiceMice, Inbred C57BLPlasmodium bergheiReinfectionT-Lymphocytes, Helper-InducerInterleukin-10Interleukin-15

Identifiers

PMID38305633
PMCPMC10932862
OpenAlexW4391485721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.